Evergreen Capital Management LLC Regeneron Pharmaceuticals, Inc. Transaction History

Evergreen Capital Management LLC

$2.75 Billion
Q3 2024

A detailed history of Evergreen Capital Management LLC transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Evergreen Capital Management LLC holds 835 shares of REGN stock, worth $564,284. This represents 0.03% of its overall portfolio holdings.

Number of Shares

835

Previous 3,695 77.4%

Holding current value

$564,284

Previous $3.88 Million 77.41%

% of portfolio

0.03%

Previous 0.15%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$1024.09 - $1201.76 $2.93 Million - $3.44 Million	-2,860 Reduced 77.4%	835 $877,000
Q2 2024 Aug 14, 2024	BUY	$883.2 - $1071.19 $48,576 - $58,915	55 Added 1.51%	3,695 $3.88 Million
Q1 2024 May 15, 2024	SELL	$902.69 - $993.35 $1.17 Million - $1.28 Million	-1,291 Reduced 26.18%	3,640 $3.5 Million
Q4 2023 Feb 14, 2024	SELL	$775.18 - $881.7 $71,316 - $81,116	-92 Reduced 1.83%	4,931 $4.33 Million
Q3 2023 Nov 14, 2023	SELL	$692.45 - $844.37 $1.45 Million - $1.77 Million	-2,091 Reduced 29.39%	5,023 $4.13 Million
Q2 2023 Aug 14, 2023	BUY	$700.03 - $830.35 $60,902 - $72,240	87 Added 1.24%	7,114 $5.11 Million
Q1 2023 May 15, 2023	SELL	$680.49 - $826.97 $17,012 - $20,674	-25 Reduced 0.35%	7,027 $5.77 Million
Q4 2022 Feb 14, 2023	SELL	$705.89 - $766.39 $52,235 - $56,712	-74 Reduced 1.04%	7,052 $5.09 Million
Q3 2022 Nov 14, 2022	SELL	$573.97 - $724.32 $67,728 - $85,469	-118 Reduced 1.63%	7,126 $4.91 Million
Q2 2022 Aug 15, 2022	BUY	$548.35 - $738.84 $1.5 Million - $2.02 Million	2,728 Added 60.41%	7,244 $4.28 Million
Q1 2022 May 16, 2022	BUY	$595.12 - $698.43 $39,277 - $46,096	66 Added 1.48%	4,516 $3.15 Million
Q4 2021 Mar 11, 2022	BUY	$543.48 - $670.97 $237,500 - $293,213	437 Added 10.89%	4,450 $2.81 Million
Q3 2021 Nov 15, 2021	SELL	$574.03 - $680.96 $760,015 - $901,591	-1,324 Reduced 24.81%	4,013 $2.43 Million
Q2 2021 Aug 16, 2021	BUY	$472.8 - $558.54 $56,263 - $66,466	119 Added 2.28%	5,337 $2.98 Million
Q1 2021 May 17, 2021	BUY	$446.73 - $548.2 $2.33 Million - $2.86 Million	5,218 New	5,218 $2.47 Million

Others Institutions Holding REGN

# of Institutions

1,497

Shares Held

82.8M

Call Options Held

1.22M

Put Options Held

1.51M

View Full List

About REGENERON PHARMACEUTICALS, INC.

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $72.4B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

More about REGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Evergreen Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Evergreen Capital Management LLC with notifications on news.

Account

Evergreen Capital Management LLC Regeneron Pharmaceuticals, Inc. Transaction History